Inequities in access to visual field testing and their outcome consequences
When visual field testing is infrequent, vision loss can slip by unnoticed. Late-stage diagnosis is a common result in underserved populations. Since...
Deep research and expert guides on maintaining your visual health.
When visual field testing is infrequent, vision loss can slip by unnoticed. Late-stage diagnosis is a common result in underserved populations. Since...
Blind spots often develop gradually without symptoms. Start a free trial and take a quick visual field test to spot changes early.
Find Out NowGlaucoma disparities describe unfair differences in who gets diagnosed, treated, and supported for a group of eye diseases that can damage the optic nerve and cause vision loss. These differences are seen between communities and population groups, often tied to factors like income, race, geography, insurance coverage, and access to eye care. People in underserved communities may face barriers such as fewer eye clinics nearby, fewer screening programs, language or cultural hurdles, and higher costs for care. As a result, some groups are more likely to be diagnosed late, when the disease has already caused significant vision loss. Systemic issues like lack of awareness, transportation problems, and bias within health systems also play a role. These disparities matter because glaucoma is a leading cause of irreversible blindness but is often preventable or manageable when caught early. When access to testing and treatment is unequal, the burden of vision loss falls more heavily on already vulnerable populations, worsening health and economic inequalities. Addressing the problem requires improving access to routine eye exams, affordable treatments, culturally sensitive education, and stronger public health outreach. Reducing disparities not only preserves sight for more people but also lowers long-term costs and improves quality of life across communities.